Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Disease symbols : Gsk save search
Listeria Monocytogenes Infections Treatment Global Market Report 2024: Global Expansion in Listeria Monocytogenes Treatment Sector Predicted Amid Rising Foodborne Disease Incidence
Published: 2024-02-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: -0.63%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: -2.71%
H: 0.0%
C: 0.0%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 0.87%
H: 0.21%
C: -2.23%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 0.89%
H: 0.41%
C: 0.1%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: 0.38%
H: 2.44%
C: 1.54%
VRTX | $405.135 1.3% 280K
|
Health Technology
|
| O: 0.56%
H: 0.49%
C: -0.12%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
BIIB | $194.31 0.1% 470K
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: -2.76%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: 0.28%
H: 0.93%
C: 0.75%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: -0.21%
H: 0.34%
C: 0.07%
disease report treatment expansion global infections market
Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease
Published: 2024-02-08 (Crawled : 12:00) - globenewswire.com
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.48%
H: 0.16%
C: 0.0%
ALEC | $5.27 1.93% 63K
|
Health Technology
|
| O: 0.0%
H: 2.34%
C: -2.34%
al101 first disease alzheimer’s trial
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $16.25 1.63% 430K
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $194.31 0.1% 470K
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published: 2023-11-16 (Crawled : 22:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -2.04%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.01%
H: 0.0%
C: -2.65%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.91%
H: 0.21%
C: -0.01%
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: 0.0%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 1.05%
H: 1.44%
C: 1.15%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 2.58%
H: 0.0%
C: 0.0%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 1.42%
H: 0.0%
C: 0.0%
rare disease cell eye market
New Data for AREXVY, GSK’s RSV Vaccine, Show Potential to Help Protect Adults Aged 50 to 59 at Increased Risk for RSV Disease
Published: 2023-10-25 (Crawled : 12:00) - biospace.com/
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 0.42%
H: 0.43%
C: -0.22%
AGEN A | $6.93 20.1% 710K
|
Health Technology
|
| O: -0.12%
H: 7.47%
C: 3.21%
disease risk rsv potential show
Conquering Challenges in the Solid Tumor Market: Your Guide to FDA-EMA Indications, Regulatory Compliance, and Market Access Excellence | Disease Landscape Insights
Published: 2023-09-21 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -1.13%
H: 0.0%
C: -0.63%
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: 0.52%
H: 0.57%
C: -0.56%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.5%
H: 0.26%
C: -0.69%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: -1.47%
H: 0.0%
C: 0.0%
BMY | $49.2 0.12% 2.9M
|
Health Technology
|
| O: -0.37%
H: 1.54%
C: 0.89%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: -0.04%
H: 0.76%
C: -0.16%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.16%
H: 0.0%
C: 0.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: 0.19%
H: 0.03%
C: -1.57%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
disease tumor market
Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published: 2023-08-16 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 5.46%
H: 0.0%
C: -2.87%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: -0.67%
H: 0.0%
C: 0.0%
VTRS | News A | $11.365 1.02% 1.6M
|
Health Technology
|
| O: -0.99%
H: 1.45%
C: 1.36%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.2%
H: 0.34%
C: -0.26%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.77%
H: 0.79%
C: 0.17%
BAX | $40.965 1.4% 810K
|
Health Technology
|
| O: -0.4%
H: 0.73%
C: -0.24%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 0.56%
H: 0.0%
C: 0.0%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -1.36%
H: 0.88%
C: 0.07%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.33%
H: 0.0%
C: 0.0%
disease market
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published: 2023-06-28 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 1.75%
H: 0.06%
C: 0.06%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 1.06%
H: 0.72%
C: 0.72%
ALPMY | News | $9.53 690K
|
Manufacturing
|
| O: -1.98%
H: 0.0%
C: -0.47%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.17%
H: 0.85%
C: 0.76%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -1.21%
H: 1.17%
C: 0.91%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.59%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -1.86%
H: 0.0%
C: 0.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: -0.83%
H: 0.89%
C: 0.68%
lung disease report treatment global growth market
US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making
Published: 2023-06-22 (Crawled : 07:00) - biospace.com/
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -1.37%
H: 0.52%
C: 0.03%
AGEN A | $6.93 20.1% 710K
|
Health Technology
|
| O: -1.09%
H: 1.65%
C: -2.2%
disease control rsv
Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -3.13%
H: 0.0%
C: -0.23%
TAK | News | $13.4 0.3% 790K
|
Health Technology
|
| O: 0.13%
H: 0.71%
C: 0.65%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.14%
H: 0.28%
C: -0.11%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
covid-19 drug research global disease report impact gastrointestinal market
Addisons disease therapeutics market size to increase by USD 442 million: 41% growth to originate from North America - Technavio
Published: 2022-12-14 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -1.57%
H: 2.23%
C: 2.23%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.71%
H: 0.08%
C: -1.07%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 0.36%
H: 0.28%
C: -1.17%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: -1.27%
H: 0.14%
C: -1.21%
TECH | $64.02 1.94% 370K
|
Health Technology
|
| O: -1.84%
H: 0.92%
C: -1.2%
BIIB | $194.31 0.1% 470K
|
Health Technology
|
| O: -0.51%
H: 0.11%
C: -1.44%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: -0.25%
H: 0.25%
C: -1.59%
america disease therapeutics growth market
Sexually transmitted disease (STD) testing market size to grow by USD 29,988.27 Million: Increasing prevalence of STDs remains key growth driver - Technavio
Published: 2022-12-07 (Crawled : 00:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 1.92%
H: 0.0%
C: 0.0%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -1.41%
H: 1.75%
C: 0.66%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.5%
C: 0.36%
disease growth market
Non-steroidal Anti-inflammatory Drugs Market Research Report by Disease Indication, Drugs, Route of Administration, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-07 (Crawled : 16:00) - prnewswire.com
RBGPF | News | $52.06 4.8K
|
Consumer Non-Durables
|
| O: 0.06%
H: 3.15%
C: 0.15%
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.74%
H: 0.0%
C: -6.74%
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: -4.28%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: -0.56%
H: 0.61%
C: 0.01%
RBGLY | News | $10.59 850K
|
Manufacturing
|
| O: 0.51%
H: 0.48%
C: -0.14%
VTRS | News A | $11.365 1.02% 1.6M
|
Health Technology
|
| O: 0.0%
H: 0.55%
C: -0.27%
ZTS | $149.5 2.72% 1.9M
|
Health Technology
|
| O: -0.06%
H: 0.54%
C: -1.77%
PRGO | $30.475 1.38% 360K
|
Health Technology
|
| O: -0.09%
H: 0.47%
C: -0.28%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.98%
H: 0.24%
C: -1.78%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: 0.21%
H: 1.6%
C: 0.72%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 5.18%
H: 0.0%
C: 0.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: 0.45%
H: 0.64%
C: -0.03%
covid-19 research global disease report impact distribution market
The Global Addison's Disease Therapeutics Market is expected to grow by $442 mn from 2023-2027, accelerating at a CAGR of 6.93% during the forecast period
Published: 2022-11-30 (Crawled : 16:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -0.06%
H: 0.06%
C: -1.08%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 1.83%
H: 0.0%
C: 0.0%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 1.22%
H: 1.37%
C: 1.28%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 0.09%
H: 0.58%
C: 0.58%
ABT | News | $108.01 0.88% 1.2M
|
Health Technology
|
| O: 0.12%
H: 2.44%
C: 2.33%
BIIB | $194.31 0.1% 470K
|
Health Technology
|
| O: 5.1%
H: 1.83%
C: -0.36%
AMGN | News | $273.38 0.54% 790K
|
Health Technology
|
| O: 0.2%
H: 1.91%
C: 1.36%
global disease expected therapeutics market
Parkinson's Disease Drugs Market to Reach $10.4 Bn, Globally, by 2031 at 6.2% CAGR: Allied Market Research
Published: 2022-11-17 (Crawled : 12:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.98%
H: 0.0%
C: 0.0%
VTRS | News A | $11.365 1.02% 1.6M
|
Health Technology
|
| O: -1.62%
H: 1.01%
C: 0.55%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -1.56%
H: 1.64%
C: 1.47%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -2.04%
H: 1.21%
C: 1.09%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: -0.59%
H: 1.39%
C: 0.79%
BIIB | $194.31 0.1% 470K
|
Health Technology
|
| O: -0.98%
H: 1.97%
C: 1.68%
research disease parkinson's market
USD 45.37 Mn incremental growth expected in Darier Disease Drugs Market -- Driven by an increase in demand for advanced dermatological diagnosis
Published: 2022-09-29 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: -3.32%
H: 4.73%
C: 4.73%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 1.87%
H: 0.0%
C: 0.0%
VTRS | News A | $11.365 1.02% 1.6M
|
Health Technology
|
| O: -1.26%
H: 0.7%
C: -0.23%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: 0.17%
H: 1.1%
C: 0.16%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.14%
H: 0.53%
C: -0.2%
BHC | $8.5 0.59% 820K
|
Health Technology
|
| O: -1.2%
H: 0.0%
C: -5.83%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: 0.17%
H: 0.28%
C: -1.47%
disease expected dermatological growth market
Global Chronic Obstructive Pulmonary Disease Treatment Market to Surpass US$ 25,601.45 Million by 2030 - Coherent Market Insights
Published: 2022-09-08 (Crawled : 18:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 2.63%
H: 0.0%
C: -3.84%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 6.1%
H: 0.13%
C: -1.44%
NVSEF | News | $95.11 490
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -1.42%
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.75%
H: 1.17%
C: 1.16%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -1.84%
H: 2.04%
C: 1.94%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: -0.47%
H: 1.85%
C: 1.31%
treatment global disease market
Global Acquired von Willebrand Disease (AvWD) Treatment Market Report 2022-2030 Featuring Key Players - Novo Nordisk A/S, Genentech, Inc., F. Hoffman-La Roche AG, Sanofi SA
Published: 2022-07-25 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $128.31 2.44% 2.2M
|
Health Technology
|
| O: 0.83%
H: 0.67%
C: 0.32%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 0.76%
H: 0.19%
C: -1.06%
SNY | News | $47.85 1.49% 920K
|
Health Technology
|
| O: 2.0%
H: 0.0%
C: 0.0%
treatment global disease report roche acquired sanofi market
Breakthroughs In Treating Killer Diseases Could Lengthen Life
Published: 2022-06-07 (Crawled : 15:00) - prnewswire.com
GLAXF | News | $20.305 630
|
Health Technology
|
| O: 0.0%
H: 0.86%
C: 0.84%
AZNCF | News | $138.73 3.7K
|
Health Technology
|
| O: 4.83%
H: 0.0%
C: -5.0%
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: 0.37%
H: 3.03%
C: 2.98%
LLY | News | $741.37 1.37% 800K
|
Health Technology
|
| O: -3.62%
H: 0.0%
C: 0.0%
AZN | News | $70.87 1.06% 3M
|
Health Technology
|
| O: 0.54%
H: 2.78%
C: 2.69%
life disease
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | News | $97.31 2.3% 2.3M
|
Health Technology
|
| O: -0.31%
H: 0.53%
C: -0.19%
GSK | News | $41.13 1.33% 1.1M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
BHC | $8.5 0.59% 820K
|
Health Technology
|
| O: -0.72%
H: 1.09%
C: -9.3%
ABBV | News | $170.19 1.37% 1.6M
|
Health Technology
|
| O: -0.17%
H: 0.59%
C: -1.52%
ACAD | News | $16.83 -0.94% 520K
|
Health Technology
|
| O: -3.61%
H: 1.39%
C: -3.14%
europe disease growth market
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.